GO:0034499 late endosome to Golgi transport: Retrograde Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034499 late endosome to Golgi transport describes the directed movement of substances from late endosomes back to the Golgi apparatus.
• This retrograde pathway is distinct from endocytic recycling to the plasma membrane and from late endosome-to-lysosome degradation.
• Key molecular players include RAB7, RAB9, the retromer complex, SNAREs such as VAMP4/Stx6/Stx7/Vti1b, and cholesterol-rich membrane domains.
• The pathway is exploited by toxins such as Shiga toxin and ricin to reach the Golgi and endoplasmic reticulum.
• Dysregulation of late endosome to Golgi transport is implicated in cancer, neurodegeneration, and lysosomal storage disorders.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of this transport step in human cells.
Description
Late endosome to Golgi transport (GO:0034499) is a retrograde membrane trafficking route that moves cargo from late endosomes back to the Golgi apparatus. This pathway is essential for retrieving receptors and lipids from the degradative endolysosomal system and for maintaining Golgi homeostasis. Unlike the canonical anterograde route from Golgi to late endosome, this retrograde step requires distinct machinery, including RAB7 and RAB9 GTPases, the retromer complex, and specific SNARE proteins. Researchers study GO:0034499 because it controls the fate of internalized cargo, influences toxin entry, and is hijacked or disrupted in multiple human diseases. Understanding this transport step at molecular resolution is critical for developing therapies that target endosomal trafficking.
late endosome to Golgi transport At A Glance
| GO ID | GO:0034499 |
|---|---|
| GO term | late endosome to Golgi transport |
| Ontology | biological_process |
| Synonym | prevacuolar endosome to Golgi transport, PVE to Golgi transport |
| Major function | Retrograde transport of cargo from late endosomes to the Golgi apparatus |
| Directionality | Retrograde (late endosome to Golgi) |
| Key compartments | Late endosome, Golgi apparatus |
| Representative cargo | Shiga toxin, ricin, MT1-MMP, receptors |
| Associated machinery | RAB7, RAB9, retromer, SNAREs (VAMP4/Stx6/Stx7/Vti1b) |
What Is GO:0034499?
GO:0034499 late endosome to Golgi transport is defined as the directed movement of substances from late endosomes to the Golgi apparatus. It is a biological process that operates in the retrograde direction relative to the secretory pathway, retrieving cargo that would otherwise be delivered to lysosomes for degradation. This term encompasses the vesicular and tubular carriers that bud from late endosomes and fuse with Golgi membranes, as well as the regulatory proteins that ensure cargo selectivity and directionality.
Why Is late endosome to Golgi transport Important in Cell Biology?
Late endosome to Golgi transport is a central node in endomembrane trafficking that determines whether internalized cargo is recycled or degraded. It is required for the retrieval of hydrolase receptors and for maintaining the lipid and protein composition of the Golgi. Pathogens and toxins, including Shiga toxin and ricin, exploit this route to reach the endoplasmic reticulum and exert cytotoxicity. Defects in this pathway are linked to cancer progression, neurodegeneration, and lysosomal storage diseases. Consequently, GO:0034499 is a high-value target for both mechanistic cell biology and therapeutic intervention.
• Maintains Golgi homeostasis by retrieving resident proteins and lipids from late endosomes.
• Controls the fate of internalized receptors, influencing cell signaling and nutrient uptake.
• Enables Shiga toxin and ricin to reach the Golgi and ER, making it a therapeutic target for toxin-mediated disease.
• Regulates delivery of MT1-MMP in macrophages, impacting extracellular matrix remodeling.
• Involves RAB7 and RAB9 GTPases whose dysfunction is linked to neurodegeneration.
• Requires cholesterol-rich membrane domains, connecting lipid metabolism to trafficking.
• Provides a model for studying retromer-dependent cargo sorting.
• Is co-opted by intracellular pathogens to establish infection.
• Dysregulation contributes to lysosomal storage disorders and cancer.
• Offers CRISPR-tractable targets for modulating retrograde transport.
What Happens During late endosome to Golgi transport?
Cargo selection at the late endosome
In simple terms: The cell decides which proteins to send back to the Golgi instead of destroying them.
Late endosomes are sorting stations where cargo destined for the Golgi is segregated from cargo destined for lysosomes. This selection depends on specific sorting signals and on the retromer complex, which recognizes cargo and packages it into retrograde carriers. Cholesterol-rich membrane microdomains also influence this sorting step.
Vesicle and tubule formation
In simple terms: The late endosome buds off small carriers that will travel to the Golgi.
Retrograde carriers bud from late endosomes as vesicles or tubules. This process requires RAB7 and RAB9 GTPases, which recruit effector proteins and coordinate membrane deformation. The ESCRT machinery and RAB conversion events contribute to the dynamic remodeling of the endosomal membrane.
Transport and tethering to the Golgi
In simple terms: The carriers move through the cytoplasm and are captured at the Golgi surface.
After budding, retrograde carriers are transported along cytoskeletal tracks toward the Golgi. Tethering factors and RAB effectors mediate the initial contact between the carrier and the Golgi membrane. This step ensures that cargo is delivered to the correct destination.
SNARE-mediated fusion
In simple terms: The carrier fuses with the Golgi membrane, releasing its cargo.
Fusion of retrograde carriers with the Golgi requires trans-SNARE complexes. The VAMP4/Stx6/Stx7/Vti1b complex is a key regulator of Golgi to late endosome transport and is also implicated in the reverse direction. SNARE pairing provides the specificity needed for directed fusion.
Cargo release and recycling of machinery
In simple terms: Once cargo is delivered, the transport machinery is reused for another round.
After fusion, cargo is released into the Golgi lumen or membrane, and SNAREs and RABs are recycled for subsequent rounds of transport. This recycling is essential for maintaining the steady-state distribution of membranes and proteins.
Key Genes Involved in GO:0034499 late endosome to Golgi transport
The following genes and proteins are experimentally implicated in late endosome to Golgi transport (GO:0034499) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB7 | Late endosome identity and retrograde transport | GTPase controlling endosome maturation and cargo exit |
| RAB9 | Retrograde transport from late endosome to Golgi | Key regulator of the pathway |
| VPS35 | Retromer cargo recognition | Component of retromer complex mediating sorting |
| VPS26 | Retromer cargo recognition | Retromer subunit required for retrograde transport |
| VPS29 | Retromer cargo recognition | Retromer subunit involved in cargo selection |
| SNX1 | Retromer-associated sorting nexin | Tubule formation and cargo sorting |
| SNX2 | Retromer-associated sorting nexin | Membrane remodeling in retrograde transport |
| VAMP4 | SNARE mediating fusion | Part of VAMP4/Stx6/Stx7/Vti1b complex |
| STX6 | SNARE mediating fusion | Golgi-localized SNARE for retrograde fusion |
| STX7 | SNARE mediating fusion | Endosomal SNARE in retrograde transport |
| VTI1B | SNARE mediating fusion | SNARE required for Golgi to late endosome transport |
| MT1-MMP | Cargo protein | Transported via VAMP4/Stx6/Stx7/Vti1b in macrophages |
| CHC1 | Clathrin heavy chain | Involved in carrier formation |
| CLTC | Clathrin heavy chain | Vesicle coat component |
| ESCRT-0 | Endosomal sorting | RAB conversion and cargo sorting |
| ESCRT-III | Membrane scission | Carrier formation and RAB conversion |
| Shiga toxin B subunit | Toxin cargo | Exploits pathway to reach Golgi |
| Ricin | Toxin cargo | Requires cholesterol for endosome to Golgi transport |
How Is late endosome to Golgi transport Regulated?
Late endosome to Golgi transport is regulated by RAB GTPase cycles, including RAB7-to-RAB9 conversion events that are coordinated by the ESCRT machinery. Cholesterol levels in endosomal membranes modulate the efficiency of ricin transport to the Golgi. SNARE complex formation, particularly the VAMP4/Stx6/Stx7/Vti1b complex, provides a regulatory checkpoint for fusion specificity. Additionally, autophagic flux and lysosomal fusion pathways can indirectly influence retrograde transport by altering late endosome dynamics.
late endosome to Golgi transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAB7 | Neurodegeneration, Charcot-Marie-Tooth disease | Knockout and point-mutation iPSC-derived neurons |
| RAB9 | Endolysosomal trafficking defects | Knockout HeLa cells |
| VPS35 | Parkinson's disease, retromer dysfunction | Knock-in mutant mice |
| VAMP4 | Cancer invasion, MT1-MMP trafficking | Knockout macrophages |
| STX6 | Cancer, Golgi trafficking | Overexpression in cancer cell lines |
Cancer and tumor progression
Altered endosomal trafficking, including late endosome to Golgi transport, contributes to cancer cell signaling and invasion. MT1-MMP transport via the VAMP4/Stx6/Stx7/Vti1b complex in macrophages highlights how this pathway impacts the tumor microenvironment. Targeting retrograde transport may offer therapeutic opportunities in cancers dependent on growth factor receptor recycling.
Neurodegeneration
RAB7 and RAB9 dysfunction is linked to neurodegenerative diseases characterized by endolysosomal defects. Impaired retrograde transport can lead to accumulation of toxic protein aggregates and neuronal death. Understanding GO:0034499 provides insight into pathogenic mechanisms of diseases such as Alzheimer's and Parkinson's.
Toxin-mediated disease
Shiga toxin and ricin exploit late endosome to Golgi transport to reach the endoplasmic reticulum and exert cytotoxicity. Inhibiting this pathway is a therapeutic strategy for Shiga toxin-producing E. coli infections. Cholesterol depletion blocks ricin transport, identifying membrane composition as a target.
Lysosomal storage disorders
Defects in endosomal sorting and retrograde transport can cause lysosomal storage disorders by misrouting hydrolases and their receptors. The retromer complex, central to GO:0034499, is implicated in sorting defects underlying these diseases. Modulating this pathway may restore proper enzyme delivery.
From late endosome to Golgi transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is RAB7 required for late endosome to Golgi transport? | RAB7 knockout HeLa cells |
| Does a point mutation in VPS35 affect cargo sorting? | VPS35 point-mutation knock-in cells |
| Can we visualize retrograde transport in live cells? | Tagged knock-in of RAB9 with fluorescent protein |
| Does overexpression of VAMP4 enhance MT1-MMP transport? | VAMP4 overexpression in macrophages |
| Which genes regulate Shiga toxin transport? | CRISPR library screening in HeLa cells |
| Does cholesterol depletion block ricin transport? | Cholesterol-auxotroph cell lines |
How to Study the late endosome to Golgi transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence microscopy | Carrier dynamics and fusion events | Visualizing RAB9-positive carriers |
| Proximity labeling proteomics | Protein-protein interactions | Mapping SNARE complexes |
| Shiga toxin sulfation assay | Transport to Golgi | Quantifying retrograde flux |
| Ricin cytotoxicity assay | Functional transport | Testing inhibitors |
| CRISPR knockout screening | Gene requirement | Identifying novel regulators |
| RNA-seq | Transcriptional changes | Pathway adaptation |
| Western blot | Protein levels and modifications | Validating knockout efficiency |
Fluorescence imaging and live-cell tracking
Fluorescently tagged cargo and organelle markers enable real-time visualization of late endosome to Golgi transport. Live-cell imaging with RAB9-GFP and Golgi markers reveals carrier dynamics. This method is essential for quantifying transport kinetics.
Proteomics and interactomics
Affinity purification of retromer components followed by mass spectrometry identifies cargo and accessory proteins. Proximity labeling can map the interactome of SNAREs involved in fusion. These approaches define the molecular machinery of GO:0034499.
Toxin-based transport assays
Shiga toxin and ricin are used as probes to measure endosome-to-Golgi transport efficiency. Sulfation assays and cytotoxicity readouts quantify transport. Cholesterol depletion experiments demonstrate the lipid dependence of this pathway.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens identify genes required for retrograde transport. Validation of hits with focused libraries reveals novel regulators. This method is powerful for discovering therapeutic targets.
How CRISPR Can Be Used to Study GO:0034499 late endosome to Golgi transport
Knockout
CRISPR knockout of RAB7, RAB9, or retromer components abolishes late endosome to Golgi transport, providing causal evidence for their requirement. Knockout cell lines are used to measure transport defects with toxin assays. These models are essential for validating gene function in GO:0034499.
Point Mutation
Point mutations in RAB7 or VPS35 can mimic disease-associated variants and reveal their impact on retrograde transport. CRISPR point-mutation knock-in allows precise modeling of human mutations. Such models are valuable for drug testing.
Knock-in
Tagged knock-in of RAB9 or VAMP4 with fluorescent proteins enables live-cell imaging of retrograde carriers. Knock-in of epitope tags facilitates proteomic analysis of transport complexes. These models preserve endogenous regulation.
Overexpression
Overexpression of VAMP4 or Stx6 can enhance or disrupt transport, revealing rate-limiting steps. CRISPR-mediated overexpression via safe-harbor integration provides tunable expression. This approach is useful for gain-of-function studies.
How EDITGENE Supports late endosome to Golgi transport Research
Researchers studying late endosome to Golgi transport-related genes often need to determine whether a candidate gene is causally involved in this retrograde pathway or merely correlated with it. EDITGENE provides CRISPR-based cell models and screening services to establish causality and mechanism.
Contact EDITGENE today to design your custom CRISPR model for late endosome to Golgi transport research.
Frequently Asked Questions About late endosome to Golgi transport
What is late endosome to Golgi transport?
It is the directed movement of substances from late endosomes back to the Golgi apparatus, defined as GO:0034499.
What genes are involved in late endosome to Golgi transport?
Key genes include RAB7, RAB9, VPS35, VAMP4, STX6, STX7, and VTI1B.
What is the GO ID for late endosome to Golgi transport?
The GO ID is GO:0034499.
How is late endosome to Golgi transport regulated?
It is regulated by RAB GTPase cycles, cholesterol levels, and SNARE complex formation.
Which toxins exploit late endosome to Golgi transport?
Shiga toxin and ricin exploit this pathway to reach the Golgi and endoplasmic reticulum.
What diseases are linked to defects in this pathway?
Cancer, neurodegeneration, toxin-mediated disease, and lysosomal storage disorders.
What methods study late endosome to Golgi transport?
Live-cell imaging, proteomics, toxin assays, and CRISPR screening.
Can CRISPR knockout validate genes in this pathway?
Yes, knockout of RAB7 or RAB9 abolishes retrograde transport, confirming their requirement.
What is the role of cholesterol in this pathway?
Cholesterol-rich membrane domains are required for ricin transport from endosomes to the Golgi.
How does the retromer complex function in this pathway?
The retromer complex selects cargo at late endosomes for retrograde delivery to the Golgi.
Conclusion
GO:0034499 late endosome to Golgi transport is a fundamental retrograde trafficking pathway that retrieves cargo from late endosomes to the Golgi, with critical roles in cell homeostasis, toxin entry, and disease. Its molecular machinery, including RAB GTPases, retromer, and SNAREs, is well-defined and experimentally tractable. CRISPR-based models and screening approaches continue to uncover new regulators and therapeutic opportunities.
References
- 1. Scott CC et al.. 2014. Endosome maturation, transport and functions.. Semin Cell Dev Biol 31:2-10 PMID: 24709024
- 2. Mauthe M et al.. 2018. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion.. Autophagy 14(8):1435-1455 PMID: 29940786
- 3. Li D et al.. 2020. Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy.. Toxins (Basel) 12(5) PMID: 32456007
- 4. Grimmer S et al.. 2000. Endosome to Golgi transport of ricin is regulated by cholesterol.. Mol Biol Cell 11(12):4205-16 PMID: 11102518
- 6. Maxfield FR et al.. 2004. Endocytic recycling.. Nat Rev Mol Cell Biol 5(2):121-32 PMID: 15040445
- 7. Solinger JA et al.. 2025. ESCRTing the RABs through conversion.. Biochem Soc Trans 53(2):431-445 PMID: 40605338
- 8. West ZE et al.. 2021. The trans-SNARE complex VAMP4/Stx6/Stx7/Vti1b is a key regulator of Golgi to late endosome MT1-MMP transport in macrophages.. Traffic 22(11):368-376 PMID: 34476885
